Explore the vast range of titles available.

The Serappis (SEarch for RAre PP-neutrinos In Scintillator) project aims at a precision measurement of the flux of solar pp neutrinos on the few-percent level. Such a measurement will be a relevant contribution to the study of solar neutrino oscillation parameters and a sensitive test of the equilibrium between solar energy output in neutrinos and electromagnetic radiation (solar luminosity constraint). The concept of Serappis relies on a small organic liquid scintillator detector (∼20 m3) with excellent energy resolution (∼2.5% at 1 MeV), low internal background and sufficient shielding from surrounding radioactivity. This can be achieved by a minor upgrade of the OSIRIS facility at the site of the JUNO neutrino experiment in southern China. To go substantially beyond current accuracy levels for the pp flux, an organic scintillator with ultra-low 14C levels (below 10-18) is required. The existing OSIRIS detector and JUNO infrastructure will be instrumental in identifying suitable scintillator materials, offering a unique chance for a low-budget high-precision measurement of a fundamental property of our Sun that will be otherwise hard to access.

The Serappis (SEarch for RAre PP-neutrinos In Scintillator) project aims at a precision measurement of the flux of solar \\(pp\\) neutrinos on the few-percent level. Such a measurement will be a relevant contribution to the study of solar neutrino oscillation parameters and a sensitive test of the solar luminosity constraint. The concept of Serappis relies on a small organic liquid scintillator detector (\\(\\sim\\)20 m\\(^3\\)) with excellent energy resolution (\\(\\sim\\)2.5 % at 1 MeV), low internal background and sufficient shielding from surrounding radioactivity. This can be achieved by a minor upgrade of the OSIRIS facility at the site of the JUNO neutrino experiment in southern China. To go substantially beyond current accuracy levels for the \\(pp\\) flux, an organic scintillator with ultra-low \\(^{14}\\)C levels (below \\(10^{-18}\\)) is required. The existing OSIRIS detector and JUNO infrastructure will be instrumental in identifying suitable scintillator materials, offering a unique chance for a low-budget high-precision measurement of a fundamental property of our Sun that will be otherwise hard to access.

The Jiangmen Underground Neutrino Observatory (JUNO), a 20 kton multi-purpose underground liquid scintillator detector, was proposed with the determination of the neutrino mass hierarchy as a primary physics goal. It is also capable of observing neutrinos from terrestrial and extra-terrestrial sources, including supernova burst neutrinos, diffuse supernova neutrino background, geoneutrinos, atmospheric neutrinos, solar neutrinos, as well as exotic searches such as nucleon decays, dark matter, sterile neutrinos, etc. We present the physics motivations and the anticipated performance of the JUNO detector for various proposed measurements. By detecting reactor antineutrinos from two power plants at 53-km distance, JUNO will determine the neutrino mass hierarchy at a 3-4 sigma significance with six years of running. The measurement of antineutrino spectrum will also lead to the precise determination of three out of the six oscillation parameters to an accuracy of better than 1\\%. Neutrino burst from a typical core-collapse supernova at 10 kpc would lead to ~5000 inverse-beta-decay events and ~2000 all-flavor neutrino-proton elastic scattering events in JUNO. Detection of DSNB would provide valuable information on the cosmic star-formation rate and the average core-collapsed neutrino energy spectrum. Geo-neutrinos can be detected in JUNO with a rate of ~400 events per year, significantly improving the statistics of existing geoneutrino samples. The JUNO detector is sensitive to several exotic searches, e.g. proton decay via the \\(p\\to K^++\\bar\\nu\\) decay channel. The JUNO detector will provide a unique facility to address many outstanding crucial questions in particle and astrophysics. It holds the great potential for further advancing our quest to understanding the fundamental properties of neutrinos, one of the building blocks of our Universe.

Genetic factors predispose individuals to Behçet’s disease (BD) and periodontal disease. IL-1 has been implicated in the pathogenesis of both BD and periodontal disease. The relationship between periodontitis and pathogenesis of BD has not yet been determined. Since IL-1 has been implicated in the pathogenesis of both BD and periodontal disease, we aimed to investigate the possible relation of the periodontal scores and SNPs of IL-1α−889C/T, IL-1β−511C/T, and IL-1β+3962T/C with BD compared to healthy controls (HC) and recurrent aphtous stomatitis (RAS). A total of 155 Turkish individuals were enrolled in this study. The periodontal status of all subjects was evaluated according to the WHO community periodontal index of treatment needs. For genotyping, CTS-PCR-SSP was employed. IL-1α−889C allele was significantly higher in BD patients ( p  = 0.03) and RAS ( p  = 0.02) compared to HC. The frequency of IL-1β+3962T allele was significantly higher in RAS patients compared to HC ( p  = 0.015). Male gender ( p  = 0.04), age ( p  = 0.02) and carrying IL-1β−511T allele ( p  = 0.01) were found to be a significant risk factors for higher periodontal scores in Turkish population. We can speculate that susceptibility to the development of periodontal disease could be influenced by IL-1 SNPs. Periodontitis-induced autoinflammatory response also may play a role in the development/severity of BD and RAS via IL-1 gene alteration.

Mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS) is a common medically intractable epilepsy syndrome. Although pathogenesis of HS still remains highly controversial, genetics may play a role as a predisposing factor. Previous evidence in a Japanese population revealed that the homozygotes for allele T at position −511 of the interleukin (IL)-1β gene promoter region (IL-1β-511 T/T) confers susceptibility to the development of HS. However, whether this polymorphism has an effect on IL-1β levels in MTLE-HS patients was not demonstrated. This study aimed to analyze the distribution of this particular polymorphism in a group of Turkish HS patients and correlate the polymorphism with IL-1β secretion from the lymphocytes, thus revealing a functional role for IL-1β in the etiopathogenesis of HS. A single base pair polymorphism at position −511 in the promoter region of the IL-1β gene was analyzed. The spontaneous and 1 ng/mL lipopolysaccharide-stimulated production of IL-1β by peripheral blood mononuclear cells after 4 and 24 h of incubation were measured by ELISA method. The heterozygous type (−511 C/T) was the most common genotype. There was no difference in frequency of allele −511 T between patients and controls. Analysis of IL-1β levels, genotype and allele distributions showed no significant difference among the groups (P>0.05). Nevertheless, it was seen that patients who carry a T allele at position -511 of the IL-1β gene had increased IL-1β levels. T-allele carriage may be important. Only IL-1β secretion from the lymphocytes has been assessed in this study. Considering the importance of IL-1β in the etiopathogenesis of HS, further studies are needed to evaluate locally produced IL-1β levels.

Genetic factors predispose individuals to Behçet's disease (BD) and periodontal disease. IL-1 has been implicated in the pathogenesis of both BD and periodontal disease. The relationship between periodontitis and pathogenesis of BD has not yet been determined. Since IL-1 has been implicated in the pathogenesis of both BD and periodontal disease, we aimed to investigate the possible relation of the periodontal scores and SNPs of IL-1alpha-889C/T, IL-1beta-511C/T, and IL-1beta+3962T/C with BD compared to healthy controls (HC) and recurrent aphtous stomatitis (RAS). A total of 155 Turkish individuals were enrolled in this study. The periodontal status of all subjects was evaluated according to the WHO community periodontal index of treatment needs. For genotyping, CTS-PCR-SSP was employed. IL-1alpha-889C allele was significantly higher in BD patients (p = 0.03) and RAS (p = 0.02) compared to HC. The frequency of IL-1beta+3962T allele was significantly higher in RAS patients compared to HC (p = 0.015). Male gender (p = 0.04), age (p = 0.02) and carrying IL-1beta-511T allele (p = 0.01) were found to be a significant risk factors for higher periodontal scores in Turkish population. We can speculate that susceptibility to the development of periodontal disease could be influenced by IL-1 SNPs. Periodontitis-induced autoinflammatory response also may play a role in the development/severity of BD and RAS via IL-1 gene alteration.

Genetic factors predispose individuals to Behçet's disease (BD) and periodontal disease. IL-1 has been implicated in the pathogenesis of both BD and periodontal disease. The relationship between periodontitis and pathogenesis of BD has not yet been determined. Since IL-1 has been implicated in the pathogenesis of both BD and periodontal disease, we aimed to investigate the possible relation of the periodontal scores and SNPs of IL-1α-889C/T, IL-1β-511C/T, and IL-1β+3962T/C with BD compared to healthy controls (HC) and recurrent aphtous stomatitis (RAS). A total of 155 Turkish individuals were enrolled in this study. The periodontal status of all subjects was evaluated according to the WHO community periodontal index of treatment needs. For genotyping, CTS-PCR-SSP was employed. IL-1α-889C allele was significantly higher in BD patients (p = 0.03) and RAS (p = 0.02) compared to HC. The frequency of IL-1β+3962T allele was significantly higher in RAS patients compared to HC (p = 0.015). Male gender (p = 0.04), age (p = 0.02) and carrying IL-1β-511T allele (p = 0.01) were found to be a significant risk factors for higher periodontal scores in Turkish population. We can speculate that susceptibility to the development of periodontal disease could be influenced by IL-1 SNPs. Periodontitis-induced autoinflammatory response also may play a role in the development/severity of BD and RAS via IL-1 gene alteration. [PUBLICATION ABSTRACT]

Prolonged oral etoposide has antitumor activity in a variety of solid tumors including small cell and non-small-cell lung cancer. A total of 53 patients have been treated with prolonged oral etoposide at a dosage of 50-100 mg/day for 5, 7,10 or 14 days in a 21 days interval. The results of these patients were retrospectively evaluated. Twelve patients had small cell lung carcinoma (SCLC), 11 patients had non-small cell lung carcinoma (NSCLC) and 30 patients had different solid tumors including gastric, breast, ovarian and prostate carcinoma. Fifty-two patients were evaluated for response analysis. Objective response rate was found to be 19,2% (1,9% complete response (CR), 17,3% partial response (PR)). Stable disease was achieved in 30,8% of the patients. Grade 3 and 4 neutropenia occurred in 9,3% of the patients. We demonstrated a modest activity of single agent oral etoposide in our heterogenous group of patients with advanced and refractory disease. Oral etoposide may be a treatment choice for patients with refractory disease which there was no other alternative without supportive care.

A growing body of data illustrates the importance of microalbuminuria (MAU) as a strong predictor of cardiovascular risk in the hypertensive population. The present study was designed to define the prevalence of MAU and associated cardiovascular risk factors among Turkish hypertensive outpatients. Representing the Turkish arm of the multinational i-SEARCH study involving 1,750 sites in 26 countries around the world, a total of 1,926 hypertensive patients from different centers were included in this observational and cross-sectional survey study. Patients with reasons for a false-positive MAU test were excluded. The prevalence of MAU was assessed using a dipstick test, and patients were inquired about comorbidities, comedication, and known cardiovascular risk factors. The overall prevalence of MAU was 64.7% and there was no difference between genders. Most of the patients (82.5%) had uncontrolled hypertension, 35.6% had dyslipidemia, and 35.5% had diabetes, predominantly type 2. Almost one-third of the patients (26.4%) had at least one cardiovascular-related comorbidity, with 20.3% having documented coronary artery disease (CAD). Almost all patients (96.8%) had one or more risk factors for cardiovascular disease in addition to hypertension, including family history of myocardial infarction or CAD, diabetes, dyslipidemia, lack of physical exercise, and smoking. A trend towards higher MAU values in the presence of CAD was determined. Microalbuminuria tests should be routinely used as a screening and monitoring tool for the assessment of subsequent cardiovascular morbidity and mortality among hypertensive patients.